Vicki Hamilton
Vicki Hamilton OAM, CEO/Secretary of the Asbestos Council of Victoria/GARDS, brings over two decades of dedicated advocacy and support for individuals affected by asbestos-related diseases. Having personally experienced the impact of asbestos-related disease through the loss of her father, grandfather and her godfather, Vicki has channelled her commitment into extensive community service. Since 2002, she […]
Gary Lee
Professor Y C Gary Lee is a Professor of Respiratory Medicine at UWA and a consultant chest physician at Sir Charles Gairdner Hospital where he set up and directs Australia’s first centralized hospital pleural service. He is a world leader in pleural research and heads a translational research group at the Institute for Respiratory Health. […]
Spiro Tzouganatos
Spiro Tzouganatos is one of Australia’s leading barristers in Dust Diseases and Toxic Torts litigation. He specialises in complex and challenging cases and has acted in many test cases relating to injuries including cancer caused by asbestos, silica, other substances, and products. Appearing in Courts and Tribunals throughout the Commonwealth including in the High Court, […]
Mary Duffy
Mary Duffy is an Advanced Practice, Clinical Nurse Consultant in the Lung Cancer Multidisciplinary Team (MDT) at the Peter Mac Callum Cancer Centre, Melbourne Australia. Mary works primarily with patients who have lung cancer or mesothelioma, and their families. Mary has worked with lung cancer patients for over 25 years in a variety of roles. […]
Catherine Jones
Professor Catherine Jones is a cardiothoracic radiologist, working in private and public practice in Brisbane. She has fellowship qualifications from the UK, Australia and Canada. She is an executive member of the Australia and New Zealand Society of Thoracic Radiologists. Catherine has extensive experience in occupational lung imaging, is a B reader with NIOSH, and […]
Wee Loong (Melvin) Chin
Dr. Chin is a medical oncologist at Sir Charles Gairdner Hospital, Western Australia. His research expertise lies in bioinformatics, artificial intelligence, and computational biology, focusing on translational aspects of mesothelioma biomarkers and prediction of mesothelioma treatment response. His research combines computational approaches with clinical expertise to develop innovative approaches for improving mesothelioma cancer care.
Anthony Linton
A/Prof Linton is the academic and research director of the Asbestos and Dust Diseases Research Institute and a senior staff specialist in medical oncology at the Concord Cancer Centre in Concord Repatriation General Hospital, specialising in thoracic and genitourinary malignancies. He received his medical degree at the University of New South Wales before completing physician […]
Sonja Klebe
Sonja Klebe is a Professor in Anatomical Pathology at Flinders University/SA Pathology at Flinders Medical Centre in South Australia and the previous interim Research Director of ADDRI (on secondment). A Graduate of Berlin Free University, with an MD in Protein Biochemistry and a PhD in Gene Therapy, her work has focused for the past 20 […]
Jaclyn Yoong
A/Prof Jaclyn Yoong is a Medical Oncologist and Palliative Care Physician from Melbourne. She works at Northern Health and Monash Health; and her primary interest is in lung cancer care and effective integration with palliative care. She completed her fellowship at Massachusetts General Hospital in Boston in 2012 and also attended the TS Chan Harvard […]
Steven Kao
A/Prof Steven Kao is a medical oncologist at the Chris O’Brien Lifehouse. He completed his PhD at the Asbestos Diseases Research Institute and focused his research on predictive and prognostic factors in mesothelioma. Steven is a keen clinical trialist focusing on thoracic oncology and continues translational research in mesothelioma and lung cancer. He was awarded […]
Susan Harden
A/Prof Susan Harden is Radiation Oncology Lead for Research at the Peter MacCallum Cancer Centre, specialising in thoracic malignancies. At Monash University Cancer Research Programme she is CIA for the Victorian Mesothelioma Outcomes Registry (VMOR) which collects and reports information on clinical treatments and quality of life through a customised patient reported outcome and experience […]
Jazmin Eckhaus
Dr Jazmin Eckhaus is an Australian-trained cardiothoracic surgeon with a sub-specialty thoracic surgical practice. She has a special interest in minimally invasive thoracic surgery and pleural disease. She has public appointments at Eastern Health and St Vincent’s Hospital. She is a founding member of the bi-national Australian and Aotearoa New Zealand Thoracic Surgical Database, which […]
Arnaud Scherpereel
Arnaud Scherpereel is Full Professor of Respiratory Medicine since 2008 in the Pulmonary and Thoracic Oncology Department. He is the head of the Heart, Lung and Vessels division in Lille University Hospital (CHU), France. Since his post-doctoral research fellowship in the University of Pennsylvania, Philadelphia, USA, he has a special focus in Thoracic Oncology and […]
Stephen Clarke
Stephen Clarke is a medical oncologist at Royal North Shore Hospital in Sydney and Professor of Medicine at the University of Sydney. He is the Director of the North Star VNP Cancer Trials Unit in Northern Sydney Local Health District. After completing his medical oncology training at Royal North Shore Hospital, Stephen undertook a PhD […]
Kelvin Lau
Mr Kelvin Lau is Clinical Director and Consultant Thoracic Surgeon at St Bartholomew’s Hospital, London. He qualified in Oxford University where he also completed a PhD on antivascular targeting. He was awarded the only cardiothoracic surgery national training post in 2006. His training took him to pioneering centres in the world, including the Royal Brompton, […]
Solange Peters
Solange Peters, MD, PhD, is a full professor and director of medical oncology, as well as the thoracic malignancies program in the Department of Oncology at the University Hospital of Lausanne in Lausanne, Switzerland. She received both her doctorate in medicine and PhD from the University Hospital of Lausanne. After completing her clinical education in […]
Peter Spolc
Peter is a university administrator from the NSW Blue Mountains. He was diagnosed in March 2021 with stage IV ALK+ NSCLC and has since actively pursued opportunities to better understand his cancer and its treatments, and engage with the clinical and research environments. He sees his role as bringing that understanding to both practitioners and […]
Peter Young
Peter Young is a consultant interested in the human-centred design, strategy, governance, risk, and organisational transformation of service providers. He has been a member of the Board of a NSW metropolitan Local Health District and a member of the NSW Health Ministerial Advisory Committee. Peter was diagnosed with NSCLC in 2020, for which he initially […]
Matthew Peters
Matthew is professor of Respiratory Medicine at Macquarie University and Senior Specialist in Dept of Respiratory Medicine at Concord Hospital. He is a previous President of TSANZ and a passionate advocate for improvement in care and outcomes for those with and at risk of lung cancer.
Fiona Hegi-Johnson
Dr Fiona Hegi-Johnson is a Radiation Oncologist at the Peter MacCallum Cancer Centre in Victoria and Senior Research Fellow at the University of Melbourne. Clinically, she specialises in the treatment of patients with lung and breast cancer, including a subspecialty interest in stereotactic ablative body radiotherapy (SABR). Fiona is also the Chair of the TROG […]
Bryan Chan
Associate Professor Bryan Chan, BPharm (Hons I), MBBS (Hons I, Uni Medal), FRACP, MMed (Clin Epi), graduated with a Bachelor of Medicine and Surgery with first class honours and the University Medal from the University of Queensland. After being awarded Fellowship of the Royal Australasian College of Physicians, he completed a clinical research fellowship at […]
Christopher Cao
Christopher Cao is the current Thoracic Representative of the Australian and New Zealand Society of Cardiac and Thoracic Surgeons. He graduated from UNSW with First Class Honours and completed his Specialist Fellowship in Memorial Sloan Kettering Cancer Center before joining the Faculty in New York University. He is now a Clinical Professor in Sydney University […]
Tim Clay
Tim is a medical oncologist at St John of God Subiaco in WA. He completed oncology training through the Victorian Medical Oncology Training Group and an MD at St Vincents Hospital Melbourne and the University of Melbourne. He has a subspecialty interest in the management of thoracic malignancies and is active in clinical trials and […]
Wendy Cooper
Prof Wendy Cooper is a senior staff specialist pathologist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital in Sydney and Anatomical Pathology Clinical Stream Lead for NSW Health Pathology. She has extensive experience in diagnostic and molecular pathology with special interest in thoracic pathology. She is a member of the Pathology Committee […]
Lucy Corke
Dr Lucy Corke is a consultant medical oncologist at Calvary Mater Newcastle with an interest in thoracic malignancies. She graduated from the University of Queensland and completed physician and oncology training primarily at the Royal Brisbane and Women’s Hospital. She went on to complete a two-year clinical and research fellowship in Thoracic Oncology at the […]
Rachel Roberts-Thomson
Rachel is a Medical Oncologist in Adelaide, South Australia with a strong interest in treating patients with thoracic malignancies as well as melanoma. She enjoys being a Principal Investigator on clinical trials, clinical research projects as well as supervising and teaching. Her focus has been on immuno-therapeutics and targeted therapies with the excitement that exists […]
Venessa Chin
A/Prof Venessa Chin is a researcher at the Garvan Institute of Medical Research and medical oncologist at St Vincent’s Hospital in Sydney. Specialising in genomics and cancer research, her work employs advanced genomic technologies to enhance cancer diagnosis and treatment. Her research focuses for integrating novel genomics technologies to uncover novel biomarkers and therapeutic targets.
Prunella Blinman
Deme Karikios
Victoria Bray
Graham Hall
Graham has been a Patient Advocate for Lung Cancer since his diagnosis in 2018. He saw a disparity with the survival rate and level of care, between his two primary cancers, Prostate and Lung Cancer (ALK positive mutation).
Evan Dukas
Evan has a strong commitment to health, mental wellbeing, equality, diversity, social inclusion and better lives for all people.
John Cannings
John Cannings, OAM, is a retired lawyer and consultant having been involved in the Health and Pharmaceutical sectors for over 30 years, including as an investigator/quality assurance partner in a number of Research and Development projects for the Federal Department of Health.
Anita McGrath
Anita McGrath is a member of the TOGA Consumer Panel and former member of the Australasian Lung Cancer Trials Group Scientific Committee. Anita also serves on the TOGA Committee of Audit, Risk and Finance (CARF).
Susan McCullough
Susan McCullough, OAM, has been a patient research advocate for lung cancer since her recovery from a lobectomy of her right lower lobe, due to a ‘lucky find’ of adenocarcinoma in March 2003 at the age of 47.
Jessica Donington
Dr. Donington has expertise in multimodality therapy for locally advanced lung cancer, lung cancer clinical trials, and treatment for medically high-risk patients early-stage lung cancer.
